Cardiovascular (CV) disease is a major cause of mortality and morbidity, for which there is an urgent need for improved mechanistic understanding, and translation to novel diagnostic and therapeutic strategies. Computational medicine is poised to enable major breakthroughs by combining the life sciences with engineering, mathematical and computational tools including physics-based models and…
Department of Cardiology, University Medical Center Hamburg-Eppendorf, Germany (M.N.). Correspondence to: Vivek Y. Reddy, MD, Helmsley Electrophysiology Center, Mount Sinai Fuster Heart Hospital, Department of…
Tulane University School of Medicine, New Orleans, LA (K.G.). Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD (R.G.). Massachusetts Eye…
Prolonged tachycardia—a risk factor for cardiovascular morbidity and mortality—can induce cardiomyopathy in the absence of structural disease in the heart. Here, by leveraging human patient…
Background: Left bundle branch area pacing (LBBAP) may be associated with greater improvement in left ventricular ejection fraction and reduction in death or heart failure…
Robust tools for quantifying the cardiac substrate are crucial to determine with accuracy target ablation sites during an electrophysiological procedure.
Background: In patients with persistent atrial fibrillation (PersAF), catheter ablation aiming for pulmonary vein isolation (PVI) is associated with moderate clinical effectiveness. We investigated t
Electrophysiology in the West 2023 Friday, October 27, 2023, 7:00 AM – 4:30 PM, Li Ka Shing Center for Learning and Knowledge (LKSC), Palo Alto,…
Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile,…
Tulane University School of Medicine, New Orleans, LA (K.G.). Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD (R.G.). Massachusetts Eye…
BACKGROUND: Pulsed field ablation (PFA) is a novel nonthermal cardiac ablation technology based on irreversible electroporation (IRE). While areas of IRE lead to durable lesions,…
